Search results

ILLUMINATE - Increasing lutetium production while leveraging metabolic imaging to enhance theranostics effectiveness, is a new international consortium of academic and industrial leaders, with the aim to demonstrate the unique value of recently developed Metabolic Magnetic Resonance Imaging (MeMRI) visualizing chemical processes in the body to significantly improve effective application of therano

https://www.lbic.lu.se/explore-our-infrastructure/national-7t-facility/illuminate-consortium - 2025-11-29

In accordance with a decision taken at LBIC this user policy will be valid from 2025-01-01 and onward, until a new policy is published. The reason to change from yearly updates is that as LBIC has evolved, our preclinical policy has been condensed into a format that has become less and less subject to change. New policies will always be published on our homepage. For general information about LBIC

https://www.lbic.lu.se/explore-our-infrastructure/general-information/lbic-preclinical-user-policy - 2025-11-29

The following process shows what happens when using LBIC and it contains the following steps:Project PlanningUser FeesThe research board and its decisionSupport from LBIC staff for approved projectsScientific resultsOwnership and handling of dataYou can read more about each step on their page in the menu. Applying for scan timeOne question that might arise is how to apply for scan time. This can b

https://www.lbic.lu.se/explore-our-infrastructure/general-information/lbic-preclinical-user-policy/usage-process - 2025-11-29

Projects start with a meeting between the researcher and LBIC staff representing the platform requested. The main goal of this first meeting is to inform each other on the preclinical imaging possibilities available (LBIC) and to identify the scientific questions and needs of the project (researcher). Publications provided by the researcher will be used to establish the strategy of the project. In

https://www.lbic.lu.se/explore-our-infrastructure/general-information/lbic-preclinical-user-policy/usage-process/project-planning - 2025-11-29

The project costs are calculated taking external (outside LU) as well as internal grants for equipment and staff into consideration. LBIC as a core facility is dependent on external as well as internal funding. In order to keep our machine park well maintained and our research output at the cutting edge we must implement user fees. These fees are predominantly used for maintenance and service cont

https://www.lbic.lu.se/explore-our-infrastructure/general-information/lbic-preclinical-user-policy/usage-process/user-fees - 2025-11-29

All projects performed on LBIC´s preclinical imaging platforms are evaluated before acceptance with respect to possibility to perform the intended experiments successfully, given the available equipment at LBIC. This evaluation is performed by the LBIC preclinical research board (RB). Please note that in the application the intended experiments should be described in their biological or medical co

https://www.lbic.lu.se/explore-our-infrastructure/general-information/lbic-preclinical-user-policy/usage-process/research-board-and-its-decisions - 2025-11-29

LBIC has a limited staff (for staff researchers and other staff members, see homepage). LBIC staff will to the best of their ability help researchers with their projects, given the complexity of the equipment. At present, however, LBIC cannot within its budget provide full service from start to goal for research groups that have received approval for their project.As a general rule, LBIC staff wil

https://www.lbic.lu.se/explore-our-infrastructure/general-information/lbic-preclinical-user-policy/usage-process/support-lbic-staff-approved-projects - 2025-11-29

AcknowledgementsIt is the mission of LBIC to “establish and provide a major translational bio-imaging center at Lund university, combining knowledge in the fields of medical physics, preclinical and clinical medicine, chemistry, technology and applied mathematics in order to develop imaging methods for the advanced study of human morphology, cellular metabolism and physiological function in health

https://www.lbic.lu.se/explore-our-infrastructure/general-information/lbic-preclinical-user-policy/usage-process/scientific-results - 2025-11-29

Regarding ownership of raw data (spectra, animal and sample images etc.) the juridical situation has been discussed with the LU juridical department. One interpretation can be that LBIC possess ownership of such raw data, but the juridical situation is unclear.LBIC´s policy at present is:LBIC (LU) has the right to use raw data as described above, however it is recommended that prior to public use

https://www.lbic.lu.se/explore-our-infrastructure/general-information/lbic-preclinical-user-policy/usage-process/ownership-and-handling-data - 2025-11-29

Meet our scientists: Sharpness and depth that moves research forwardAn article about LBIC and Pia Sundgren.Read the article (in Swedish only at the moment, opens in new window)

https://www.lbic.lu.se/news-events - 2025-11-29

Back to TEM embedding

https://www.lbic.lu.se/tem-embedding-1 - 2025-11-29

Back to previous page

https://www.lbic.lu.se/tem-embedding-2 - 2025-11-29

Back to previous page

https://www.lbic.lu.se/tem-embedding-3 - 2025-11-29

Back to previous page

https://www.lbic.lu.se/tem-negative-staining - 2025-11-29

Preclinical and 7T publications 2018Mostajeran M, Wetterling F, Blixt FW, Edvinsson L, Ansar S. Acute mitogen-activated protein kinase 1/2 inhibition improves functional recovery and vascular changes after ischaemic stroke in rat-monitored by 9.4 T magnetic resonance imaging. Acta Physiol (Oxf). 2018 May; 223(1):e12985, doi: 10.1111/apha.12985Sanchez-Heredia JD, Avendal J, Bibic A, Lau BK. Radiati

https://www.lbic.lu.se/explore-our-infrastructure/national-7t-facility/publications-national-7t-facility/publications-2018 - 2025-11-29

If you are interested in using our services, please contact the person responsible for the facility of interest. You can also find more information about available equipment, services and how to apply under each facility.Microscopy Sebastian Wasserstrom Preclinical Nuclear MedicineRitha Gidlöf Preclinical Magnetic Resonance ImagingMichael Gottschalk Clinical Magnetic Resonance ImagingPia Sundgren 

https://www.lbic.lu.se/explore-our-infrastructure/general-information - 2025-11-29

Dummy page

https://www.lbic.lu.se/dummy-page - 2025-11-29

Lund University Bioimaging Centre (LBIC) is an infrastructure within the Medical Faculty at Lund University, housing a large variety of advanced imaging equipment and cutting-edge bioimaging techniques ranging from micro to macro. This in combination with a highly experienced and service-minded staff makes LBIC unique! Our dedicated staff scientists can offer support throughout the entire experime

https://www.lbic.lu.se/about - 2025-11-29

Preclinical and 7T publications 2017Wasserstrom S, Morén B, Stenkula KG. Total Internal Reflection Fluorescence Microscopy to Study GLUT4 Trafficking. Methods Mol Biol. (2018) 1713:151-159. Published online 08 December 2017.Horstmann P.F., Raina D.B. , Isaksson H., Hettwer W., Lidgren L., PetersenM.M., Tägil M. Composite Biomaterial as a Carrier for Bone-Active Substances for Metaphyseal Tibial Bo

https://www.lbic.lu.se/explore-our-infrastructure/national-7t-facility/publications-national-7t-facility/publications-2017 - 2025-11-29

Preclinical and 7T publications 2016Gottschalk M, Troprès I, Lamalle L, Grand S, Le Bas JF, Segebarth C. Refined modelling of the short-T2 signal component and ensuing detection of glutamate and glutamine in short-TE, localised, (1) H MR spectra of human glioma measured at 3 T. NMR Biomed. 2016 Jul;29(7):943-51. doi: 10.1002/nbm.3548Hansen JS, Krintel C, Hernebring M, Haataja TJK, de Marèa S, Wass

https://www.lbic.lu.se/explore-our-infrastructure/national-7t-facility/publications-national-7t-facility/publications-2016 - 2025-11-29